©The Author(s) 2026.
World J Diabetes. Jan 15, 2026; 17(1): 112027
Published online Jan 15, 2026. doi: 10.4239/wjd.v17.i1.112027
Published online Jan 15, 2026. doi: 10.4239/wjd.v17.i1.112027
Figure 1 Microtubule affinity-regulating kinase 4 was upregulated in diabetic cardiomyopathy models.
A and B: Microtubule affinity-regulating kinase 4 protein levels in diabetic cardiomyopathy model mice; C and D: Microtubule affinity-regulating kinase 4 protein levels in cardiomyocytes stimulated with 200 μM palmitic acid and 33.3 mmol/L glucose. Values are mean ± SD (n = 4). aP < 0.05, and bP < 0.01. Con: Control; DCM: Diabetic cardiomyopathy; MARK4: Microtubule affinity-regulating kinase 4; GAPDH: Glyceraldehyde 3-phosphate dehydrogenase; HG: High glucose.
- Citation: Wu Y, Wang WY, Zhang JQ, Wang S, Zeng Z, Fu L, Li B. Microtubule affinity-regulating kinase 4 exacerbates diabetic cardiomyopathy by inhibiting UNC-51-like kinase 1-mediated mitochondrial autophagy. World J Diabetes 2026; 17(1): 112027
- URL: https://www.wjgnet.com/1948-9358/full/v17/i1/112027.htm
- DOI: https://dx.doi.org/10.4239/wjd.v17.i1.112027